You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 21, 2024

Details for Patent: 9,427,448


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,427,448
Title:Methods of treating, reducing the incidence of, and/or preventing ischemic events
Abstract: Methods of treating, reducing the incidence of, and/or preventing an ischemic event in a patient undergoing percutaneous coronary intervention (PCI), comprising administering to the patient a pharmaceutical composition comprising cangrelor. The method may further comprise administering an additional therapeutic agent to the patient, the additional therapeutic agent comprising a P2Y.sub.12 inhibitor. Pharmaceutical compositions useful for treating, reducing the incidence of, and/or preventing an ischemic event in a patient undergoing PCI. The pharmaceutical compositions comprise cangrelor. Methods of preparing a pharmaceutical composition for treating, reducing the incidence of, and/or preventing an ischemic event in a patient undergoing PCI, comprising admixing cangrelor with one or more pharmaceutically acceptable excipients. An ischemic event may include stent thrombosis, myocardial infarction, ischemia-driven revascularization, and mortality.
Inventor(s): Arculus-Meanwell; Clive Arthur (Bernardsville, NJ), Skerjanec; Simona (Basel, CH), Prats; Jayne (Carlisle, MA)
Assignee: The Medicines Company (Parsippany, NJ)
Application Number:13/792,056
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,427,448
Patent Claim Types:
see list of patent claims
Use; Composition; Delivery;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 9,427,448: A Detailed Analysis

Introduction

Patent 9,427,448, like any other patent, is a complex document that outlines the scope and claims of an invention. To understand its implications, it is crucial to delve into the specifics of the patent, including its claims, the technology it covers, and the broader patent landscape.

Patent Overview

United States Patent 9,427,448 was granted for an invention that, while not specified in the provided sources, typically involves a detailed description of the invention, its background, and the claims that define the scope of the patent.

Claims Analysis

The claims section of a patent is the most critical part, as it defines the legal boundaries of the invention.

Independent and Dependent Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims. They are crucial because they set the broad scope of what is being patented[3].
  • Dependent Claims: These claims refer back to and further limit the independent claims. They often add specific details or narrow the scope of the invention, making the claims more specific and less likely to be challenged[3].

Claim Language and Scope

The language used in the claims is precise and technical. For example, if the patent involves AI technology, the claims would need to integrate any abstract ideas into practical applications to meet the subject matter eligibility criteria, as outlined in the 2024 USPTO guidance update[1].

Subject Matter Eligibility

The eligibility of a patent claim is a critical aspect, especially in the context of AI and software-related inventions.

Judicial Exceptions and Practical Applications

Claims must integrate judicial exceptions (such as abstract ideas or mathematical models) into practical applications to be considered patent-eligible. For instance, a claim involving an artificial neural network must demonstrate an improvement in computer technology or a specific practical application to be eligible[1].

Recent Case Law and Examples

The 2024 USPTO guidance update includes examples and recent Federal Circuit decisions to help practitioners understand how to draft claims that meet the eligibility criteria. These examples illustrate how claims can be crafted to show meaningful limits and practical applications, ensuring the invention is not merely an abstract idea[1].

Patent Scope and Breadth

The scope of a patent is a measure of how broadly or narrowly the claims cover the invention.

Metrics for Measuring Patent Scope

Research has shown that metrics such as independent claim length and independent claim count can be used to measure patent scope. Narrower claims, often resulting from a longer examination process, are associated with a higher probability of grant and shorter examination times[3].

Patent Landscape and Prior Art

Understanding the patent landscape involves searching for prior art and existing patents in the same field.

Search Tools and Resources

The USPTO provides several tools for searching patents, including the Patent Public Search tool, Global Dossier, and the Public Search Facility. These resources help in identifying prior art and ensuring that the invention is novel and non-obvious[4].

International Patent Offices

Searching international patent databases, such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO), is essential to ensure global novelty and non-obviousness[4].

Real-World Applications and Practical Utility

To bolster the argument for patent eligibility, it is crucial to highlight the real-world applications and practical utility of the claimed method or system.

Example from USPTO Guidance

For example, in the 2024 USPTO guidance, Claim 2 of Example 48 specifies the use of separated audio components in a speech recognition system to improve the accuracy of voice commands. This practical application transforms the abstract idea into a patent-eligible invention by providing a tangible benefit in the technology[1].

Industry Expert Insights

Industry experts often emphasize the importance of clear and specific claims that integrate abstract ideas into practical applications.

"The key to drafting patent-eligible claims, especially in AI and software, is to ensure that the claims specify a practical application that provides concrete benefits or solves specific problems in the relevant field."[1]

Statistics and Trends

  • Patent Scope Changes: Studies have shown that the examination process tends to narrow the scope of patent claims, with narrower claims at publication associated with a higher probability of grant and a shorter examination process[3].
  • Global Patent System: The integration of global patent databases and tools like the Common Citation Document (CCD) facilitates a more harmonized and efficient patent search process, ensuring that inventions are novel and non-obvious on a global scale[4].

Key Takeaways

  • Claims Analysis: The claims section is critical and must be carefully crafted to define the scope of the invention.
  • Subject Matter Eligibility: Claims must integrate judicial exceptions into practical applications to be patent-eligible.
  • Patent Scope: Metrics such as claim length and count can measure patent scope, with narrower claims often resulting from a longer examination process.
  • Real-World Applications: Highlighting practical utility and real-world applications is essential for demonstrating patent eligibility.
  • Global Search: Searching international patent databases is crucial for ensuring global novelty and non-obviousness.

FAQs

Q: What is the significance of independent claims in a patent? A: Independent claims stand alone and define the broad scope of the invention, setting the legal boundaries of what is being patented.

Q: How does the 2024 USPTO guidance update impact AI-related patent claims? A: The update clarifies that AI-assisted inventions are evaluated on equal footing with other technologies, focusing on whether the claimed invention integrates a judicial exception into a practical application.

Q: What metrics can be used to measure patent scope? A: Metrics such as independent claim length and independent claim count can be used to measure patent scope, with narrower claims often associated with a higher probability of grant and shorter examination times.

Q: Why is it important to search international patent databases? A: Searching international patent databases ensures that the invention is novel and non-obvious on a global scale, which is crucial for maintaining the validity of the patent.

Q: How can industry experts help in drafting patent-eligible claims? A: Industry experts can provide insights into crafting claims that specify practical applications and provide concrete benefits, ensuring that the claims meet the subject matter eligibility criteria.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. U.S. Patent and Trademark Office (USPTO) | USAGov
  3. Patent Claims and Patent Scope - SSRN
  4. Search for patents - USPTO

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,427,448

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Chiesi KENGREAL cangrelor POWDER;INTRAVENOUS 204958-001 Jun 22, 2015 RX Yes Yes 9,427,448 ⤷  Subscribe METHOD OF TREATING, REDUCING THE INCIDENCE OF, OR PREVENTING AN ISCHEMIC EVENT IN A PATIENT UNDERGOING PCI BY ADMINISTERING INTRAVENOUSLY 30 UG/KG BOLUS BEFORE PCI AND CONTINUOUS INFUSION OF 4 UG/KG/MIN FOR AT LEAST 2 HOURS OR THE DURATION OF THE PCI ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,427,448

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2009246396 ⤷  Subscribe
Australia 2010319612 ⤷  Subscribe
Australia 2012295343 ⤷  Subscribe
Australia 2013381855 ⤷  Subscribe
Australia 2016204562 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.